Spontaneous p53-reactive T-cells have been identified in more than 40% of patients with breast cancer-treated; In addition, the majority of breast cancer patients with high p53 expression have the ability to initiate p53-specific IFN-γ response [33]. Here, TP53 is linked to breast carcinoma.